scholarly article | Q13442814 |
P356 | DOI | 10.1080/10428190701534432 |
P698 | PubMed publication ID | 17786711 |
P50 | author | Gero Hütter | Q111708 |
Eckhard Thiel | Q87582542 | ||
Ulrich Keilholz | Q107526958 | ||
P2093 | author name string | Alexander Schmittel | |
Antonia Busse | |||
Jan Michael Siehl | |||
P2860 | cites work | CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma | Q28270920 |
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma | Q28297805 | ||
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP | Q28346778 | ||
Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma | Q33342531 | ||
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials | Q34199968 | ||
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. | Q34511480 | ||
Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients | Q35101292 | ||
Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies | Q35124674 | ||
Cardiac safety of liposomal anthracyclines | Q35297464 | ||
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma | Q43869754 | ||
Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity | Q44220317 | ||
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma | Q44299826 | ||
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. | Q44796944 | ||
Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening | Q46395878 | ||
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients. | Q53951659 | ||
P433 | issue | 9 | |
P921 | main subject | phase I clinical trial | Q5452194 |
P304 | page(s) | 1755-1763 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma. | |
P478 | volume | 48 |
Search more.